Next Article in Journal
Toward a SARS-CoV-2 VLP Vaccine: HBc/G as a Carrier for SARS-CoV-2 Spike RBM and Nucleocapsid Protein-Derived Peptides
Next Article in Special Issue
Anti-SARS-CoV-2 Vaccination and PIMS-TS—Friends or Foe? Case Reports and Literature Review
Previous Article in Journal
Antibody Response after 3-Dose Booster against SARS-CoV-2 mRNA Vaccine in Kidney Transplant Recipients
Previous Article in Special Issue
Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis
 
 
Article

Article Versions Notes

Vaccines 2024, 12(3), 265; https://doi.org/10.3390/vaccines12030265
Action Date Notes Link
article xml file uploaded 3 March 2024 08:54 CET Original file -
article xml uploaded. 3 March 2024 08:54 CET Update -
article pdf uploaded. 3 March 2024 08:54 CET Version of Record https://www.mdpi.com/2076-393X/12/3/265/pdf-vor
article supplementary file uploaded. 3 March 2024 08:54 CET - https://www.mdpi.com/2076-393X/12/3/265#supplementary
article html file updated 3 March 2024 08:55 CET Original file -
article xml file uploaded 8 March 2024 08:28 CET Update -
article xml uploaded. 8 March 2024 08:28 CET Update https://www.mdpi.com/2076-393X/12/3/265/xml
article pdf uploaded. 8 March 2024 08:28 CET Updated version of record https://www.mdpi.com/2076-393X/12/3/265/pdf
article html file updated 8 March 2024 08:30 CET Update https://www.mdpi.com/2076-393X/12/3/265/html
Back to TopTop